Onabotulinumtoxin A for Idiopathic Overactive Bladder: Raising the Bar

被引：1
|
作者：
Bauer, Ricarda M. [1 ]
Gratzke, Christian [1 ]
机构：
[1] Univ Munich, Univ Hosp Grosshadern, Dept Urol, D-81377 Munich, Germany
来源：
EUROPEAN UROLOGY | 2012年 / 62卷 / 01期
关键词：
QUALITY-OF-LIFE; BOTULINUM-TOXIN-A; NEPHRON-SPARING SURGERY; DETRUSOR OVERACTIVITY; DOUBLE-BLIND; INJECTIONS; SAFETY; EFFICACY; OUTCOMES; TRIAL;
D O I：
10.1016/j.eururo.2012.04.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [31] Repeat Intradetrusor Injections of Onabotulinum Toxin A for Refractory Idiopathic Overactive Bladder Patients: A Single-Center Experience
    Gousse, Angelo E.
    Kanagarajah, Prashanth
    Ayyathurai, Rajinikanth
    Handa, Priyanka
    Dabas, Nikita
    Gomez, Christopher S.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2011, 17 (05): : 253 - 257
  • [32] Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome
    Osborn, David James
    Kaufman, Melissa R.
    Mock, Stephen
    Guan, Michael J.
    Dmochowski, Roger R.
    Reynolds, W. Stuart
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 (07) : 675 - 678
  • [33] Botulinum toxin A for the Treatment of Overactive Bladder
    Hsieh, Po-Fan
    Chiu, Hung-Chieh
    Chen, Kuan-Chieh
    Chang, Chao-Hsiang
    Chou, Eric Chieh-Lung
    TOXINS, 2016, 8 (03)
  • [34] Predictors of Poor Response and Adverse Events Following Botulinum Toxin A for Refractory Idiopathic Overactive Bladder: A Systematic Review
    Abrar, Mohammad
    Pindoria, Nisha
    Malde, Sachin
    Chancellor, Michael
    DeRidder, Dirk
    Sahai, Arun
    EUROPEAN UROLOGY FOCUS, 2021, 7 (06): : 1448 - 1467
  • [35] Solifenacin succinate for the treatment of overactive bladder
    Hoffstetter, Susan
    Leong, Fah Che
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (03) : 345 - 350
  • [36] The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
    Gubbiotti, Marilena
    Giannantoni, Antonella
    Cantaluppi, Simona
    Coluccia, Anna Chiara
    Ghezzi, Fabio
    Serati, Maurizio
    BMC UROLOGY, 2019, 19 (1)
  • [37] Medium- to long-term outcomes of botulinum toxin A for idiopathic overactive bladder
    Eldred-Evans, David
    Sahai, Arun
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (01) : 3 - 10
  • [38] Current pharmacological management of idiopathic overactive bladder in children in the UK: a national survey of practice
    Melling, Charlotte Victoria
    Goyal, Anju
    JOURNAL OF PEDIATRIC UROLOGY, 2020, 16 (01) : 37.e1 - 37.e8
  • [39] Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder
    Liberman, Daniel
    Milhouse, Olufenwa
    Johnson-Mitchell, Marta
    Siegel, Steven W.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2018, 24 (06): : 404 - 407
  • [40] Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation
    Sherif, Hammouda
    Khalil, Mostafa
    Omar, Rabea
    CANADIAN JOURNAL OF UROLOGY, 2017, 24 (03) : 8838 - 8846
12345